• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富含肝的转录因子 CREBH 受到营养的调节,可被脂肪酸和 PPARα 激活。

The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalpha.

机构信息

Department of Internal Medicine (Endocrinology and Metabolism), Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba Ibaraki 305-8575, Japan.

出版信息

Biochem Biophys Res Commun. 2010 Jan 8;391(2):1222-7. doi: 10.1016/j.bbrc.2009.12.046. Epub 2009 Dec 16.

DOI:10.1016/j.bbrc.2009.12.046
PMID:20006574
Abstract

To elucidate the physiological role of CREBH, the hepatic mRNA and protein levels of CREBH were estimated in various feeding states of wild and obesity mice. In the fast state, the expression of CREBH mRNA and nuclear protein were high and profoundly suppressed by refeeding in the wild-type mice. In ob/ob mice, the refeeding suppression was impaired. The diet studies suggested that CREBH expression was activated by fatty acids. CREBH mRNA levels in the mouse primary hepatocytes were elevated by addition of the palmitate, oleate and eicosapenonate. It was also induced by PPARalpha agonist and repressed by PPARalpha antagonist. Luciferase reporter gene assays indicated that the CREBH promoter activity was induced by fatty acids and co-expression of PPARalpha. Deletion studies identified the PPRE for PPARalpha activation. Electrophoretic mobility shift assay and chromatin immunoprecipitation (ChIP) assay confirmed that PPARalpha directly binds to the PPRE. Activation of CREBH at fasting through fatty acids and PPARalpha suggest that CREBH is involved in nutritional regulation.

摘要

为了阐明 CREBH 的生理作用,我们评估了野生型和肥胖型小鼠在不同进食状态下肝脏中 CREBH 的 mRNA 和蛋白水平。在禁食状态下,野生型小鼠的 CREBH mRNA 和核蛋白表达水平较高,并在再次进食时受到强烈抑制。在 ob/ob 小鼠中,这种再进食抑制作用受损。饮食研究表明,脂肪酸激活了 CREBH 的表达。在小鼠原代肝细胞中,添加棕榈酸、油酸和二十碳五烯酸可升高 CREBH mRNA 水平。它也可被过氧化物酶体增殖物激活受体 alpha 激动剂诱导,被过氧化物酶体增殖物激活受体 alpha 拮抗剂抑制。荧光素酶报告基因分析表明,脂肪酸和过氧化物酶体增殖物激活受体 alpha 共表达可诱导 CREBH 启动子活性。缺失研究确定了 PPARalpha 激活的 PPRE。电泳迁移率变动分析和染色质免疫沉淀(ChIP)分析证实了过氧化物酶体增殖物激活受体 alpha 直接结合到 PPRE 上。在禁食状态下,脂肪酸和过氧化物酶体增殖物激活受体 alpha 的激活表明 CREBH 参与了营养调节。

相似文献

1
The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalpha.富含肝的转录因子 CREBH 受到营养的调节,可被脂肪酸和 PPARα 激活。
Biochem Biophys Res Commun. 2010 Jan 8;391(2):1222-7. doi: 10.1016/j.bbrc.2009.12.046. Epub 2009 Dec 16.
2
Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.肝脏中突变型过氧化物酶体增殖物激活受体γ的转基因表达会引发禁食诱导的脂肪变性,但可保护小鼠免受高脂饮食诱导的脂肪变性。
Metabolism. 2005 Nov;54(11):1490-8. doi: 10.1016/j.metabol.2005.05.015.
3
Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor α to regulate metabolic hormone FGF21.富含肝的转录因子 CREBH 与过氧化物酶体增殖物激活受体 α 相互作用,调节代谢激素 FGF21。
Endocrinology. 2014 Mar;155(3):769-82. doi: 10.1210/en.2013-1490. Epub 2014 Jan 1.
4
Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level.过氧化物酶体增殖物激活受体α激活大鼠肝脏丙二酰辅酶A脱羧酶基因的转录:丙二酰辅酶A水平的关键调控
Biochem J. 2004 Mar 15;378(Pt 3):983-90. doi: 10.1042/BJ20031565.
5
Identification of a functional peroxisome proliferator-activated receptor (PPAR) response element (PPRE) in the human apolipoprotein A-IV gene.人类载脂蛋白A-IV基因中功能性过氧化物酶体增殖物激活受体(PPAR)反应元件(PPRE)的鉴定。
Biochem Pharmacol. 2009 Sep 1;78(5):523-30. doi: 10.1016/j.bcp.2009.05.007. Epub 2009 May 9.
6
Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.膳食鱼油激活过氧化物酶体增殖物激活受体α可减轻脂肪变性,但由于肝脏脂质过氧化物积累,无法预防实验性脂肪性肝炎。
J Gastroenterol Hepatol. 2008 Feb;23(2):267-75. doi: 10.1111/j.1440-1746.2007.05157.x. Epub 2007 Sep 12.
7
Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.过氧化物酶体增殖物激活受体α(PPARα)缺乏会导致脂肪酸和胰岛素对肝脏脂质和碳水化合物代谢的调节异常。
Biochem J. 2002 Jun 1;364(Pt 2):361-8. doi: 10.1042/BJ20011699.
8
The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver.白细胞介素-1受体拮抗剂是肝脏中过氧化物酶体增殖物激活受体α的直接靶基因。
J Hepatol. 2007 May;46(5):869-77. doi: 10.1016/j.jhep.2006.11.019. Epub 2006 Dec 26.
9
Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice.通过激活肥胖小鼠的过氧化物酶体增殖物激活受体(PPAR)α抑制组织脂质积累来增强胰岛素信号传导。
Med Sci Monit. 2004 Oct;10(10):BR388-95. Epub 2004 Sep 23.
10
Mouse OCTN2 is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha) via a PPRE located in the first intron.鼠 OCTN2 可被过氧化物酶体增殖物激活受体 α(PPARα)直接调控,调控元件为位于第一内含子的 PPRE。
Biochem Pharmacol. 2010 Mar 1;79(5):768-76. doi: 10.1016/j.bcp.2009.10.002. Epub 2009 Oct 9.

引用本文的文献

1
Cgref1 is a CREB-H-regulated hepatokine that promotes hepatic lipogenesis by mediating epididymal fat insulin resistance.Cgref1是一种由CREB-H调节的肝因子,它通过介导附睾脂肪胰岛素抵抗来促进肝脏脂肪生成。
Int J Biol Sci. 2025 Mar 24;21(6):2568-2588. doi: 10.7150/ijbs.97008. eCollection 2025.
2
PPAR affects hepatic lipid homeostasis by perturbing necroptosis signals in the intestinal epithelium.过氧化物酶体增殖物激活受体(PPAR)通过干扰肠上皮细胞中的坏死性凋亡信号来影响肝脏脂质稳态。
Acta Pharm Sin B. 2024 Nov;14(11):4858-4873. doi: 10.1016/j.apsb.2024.08.021. Epub 2024 Aug 30.
3
Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.
非酒精性脂肪性肝病与肝纤维化分期。
Adv Exp Med Biol. 2024;1460:539-574. doi: 10.1007/978-3-031-63657-8_18.
4
CREBH Systemically Regulates Lipid Metabolism by Modulating and Integrating Cellular Functions.CREBH 系统通过调节和整合细胞功能来调节脂质代谢。
Nutrients. 2021 Sep 15;13(9):3204. doi: 10.3390/nu13093204.
5
CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins.CREBH 通过降低循环中残余脂蛋白使血脂异常正常化并阻止糖尿病患者的动脉粥样硬化进展。
J Clin Invest. 2021 Nov 15;131(22). doi: 10.1172/JCI153285.
6
The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation.转录因子 CREBH、PPARa 和 FOXO1 作为饮食诱导代谢失调的关键肝内调节介质。
J Nutr Biochem. 2021 Sep;95:108633. doi: 10.1016/j.jnutbio.2021.108633. Epub 2021 Mar 28.
7
Regulation of Hepatic Metabolism and Cell Growth by the ATF/CREB Family of Transcription Factors.转录因子 ATF/CREB 家族对肝脏代谢和细胞生长的调控。
Diabetes. 2021 Mar;70(3):653-664. doi: 10.2337/dbi20-0006.
8
Making the Best of a Competition: the CREB3L3-SREBP Axis in Arteriosclerosis.充分利用竞争:动脉硬化中的CREB3L3-SREBP轴
Cell Mol Gastroenterol Hepatol. 2021;11(4):1199-1201. doi: 10.1016/j.jcmgh.2021.01.002. Epub 2021 Feb 6.
9
Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的转录调控
Metabolites. 2020 Jul 9;10(7):283. doi: 10.3390/metabo10070283.
10
CREBH Improves Diet-Induced Obesity, Insulin Resistance, and Metabolic Disturbances by FGF21-Dependent and FGF21-Independent Mechanisms.CREBH通过依赖FGF21和不依赖FGF21的机制改善饮食诱导的肥胖、胰岛素抵抗和代谢紊乱。
iScience. 2020 Mar 27;23(3):100930. doi: 10.1016/j.isci.2020.100930. Epub 2020 Feb 21.